X

Health Care

Equillium CEO Bruce Steel: We are among the few evaluated in first-line GVHD treatment

Credit:DavidBGray on iStock What is Equillium all about? We started the company four years ago around our lead drug program…

Rite Aid Corporation (RAD) Q3 2022 Earnings Call Transcript

Rite Aid Corporation (NYSE: RAD) Q3 2022 earnings call dated Dec. 21, 2021 Corporate Participants: Trent Kruse -- Senior Vice President of…

HEXO Corp. (HEXO) Q1 2022 Earnings Call

HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith — Director, Investor Relations Scott Cooper — President, Chief…

HEXO Corp. (HEXO) Q1 2022 Earnings Call Transcript

HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith -- Director, Investor Relations Scott Cooper -- President,…

Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris -- President & Chief Executive…

Merck & Co. (MRK) stock research summary | Q3 2021

Merck is a multinational pharmaceutical company which announced its earnings call on October 28, 2021. Merck beat Zacks consensus on…

Biofrontera sees TAM of $4 Bln for lead product Ameluz: CEO Erica Monaco

Caption: iStock Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States.…

Avid Bioservices, Inc. (CDMO) Q2 2022 Earnings Call Transcript

Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim Brons -- Investor Relations, Vida Strategic…

HealthEquity, Inc. (HQY) Q3 2021 Earnings Call Transcript

HealthEquity, Inc. (NASDAQ: HQY) Q3 2021 earnings call dated Dec. 06, 2021 Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President/Chief Executive…

Eli Lilly and Company (LLY) Earnings: 3Q21 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported revenue of $6.7 billion for the third quarter of 2021, up 18% year-over-year.…

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed…

Biogen (BIIB) stock research summary | Q3 2021

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments…

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of…

Patterson Companies, Inc. (PDCO) Q2 2022 Earnings Call Transcript

Patterson Companies, Inc. (NASDAQ: PDCO) Q2 2022 earnings call dated Dec. 01, 2021 Corporate Participants: John M. Wright -- Vice President, Investor…

Biofrontera Inc (BFRI) Q3 2021 Earnings Call Transcript

Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck -- Head of Investor Relations…

BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results

Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to…

Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript

Centogene N.V.  (NASDAQ: CNTG) Q3 2021 earnings call dated Nov. 24, 2021 Corporate Participants: Lennart Streibel -- Investor Relations Andrin Oswald -- Chief Executive…

Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021

Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective…

Medtronic PLC (MDT) Q2 2022 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head -…

Colgate-Palmolive Company (CL) earnings Q3 2021 results

Colgate-Palmolive Company (NYSE: CL) reported its third-quarter financial results for the period ended September 30, 2021. GAAP net income for…

Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook

Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom…